A risk score for type 1 diabetes derived from participants in the diabetes prevention trial-type 1 (DPT-1)

被引：0
|
作者：
Sosenko, Jay M.
Krischer, Jeffrey P.
Palmer, Jerry P.
Mahon, Jeffrey
Cowie, Catherine
Greenbaum, Carla J.
Cuthbertson, David D.
Lachin, John
Skyler, Jay S.
机构：
来源：
DIABETES | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A55 / A55
页数：1
相关论文
共 50 条
  • [21] The Application of the Diabetes Prevention Trial-Type 1 Risk Score for Identifying a Preclinical State of Type 1 Diabetes
    Sosenko, Jay M.
    Skyler, Jay S.
    Mahon, Jeffrey
    Krischer, Jeffrey P.
    Beam, Craig A.
    Boulware, David C.
    Greenbaum, Carla J.
    Rafkin, Lisa E.
    Cowie, Catherine
    Cuthbertson, David
    Palmer, Jerry P.
    DIABETES CARE, 2012, 35 (07) : 1552 - 1555
  • [22] The Association of C-Peptide with BMI at the Diagnosis of Type 1 Diabetes (T1D) in Children Participating in the Diabetes Prevention Trial-Type 1 (DPT-1)
    Sosenko, Jay M.
    Evans-Molina, Carmella
    Dimeglio, Linda A.
    Rafkin, Lisa E.
    Liu, Yuk-Fun
    Skyler, Jay S.
    Palmer, Jerry P.
    DIABETES, 2016, 65 : A341 - A341
  • [23] A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type-1
    Sosenko, Jay M.
    Krisher, Jeffrey P.
    Palmer, Jerry P.
    Mahon, Jeffrey
    Cowie, Catherine
    Greenbaum, Carla J.
    Cuthbertson, David
    Lachin, John M.
    Skyler, Jay S.
    DIABETES CARE, 2008, 31 (03) : 528 - 533
  • [24] The loss of post-challenge C-peptide in the peri-onset period of type 1 diabetes in the Diabetes Prevention Trial-type 1 (DPT-1)
    Sosenko, Jay
    Palmer, Jerry
    Rafkin-Mervis, Lisa
    Krischer, Jeffrey
    Cuthbertson, David
    Matheson, Della
    Skyler, Jay
    DIABETES, 2008, 57 : A502 - A502
  • [25] The DPT-1 Trial: a negative result with lessons for future type 1 diabetes prevention
    Pozzilli, P
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2002, 18 (04) : 257 - 259
  • [26] Incident Dysglycemia and Progression to Type 1 Diabetes Among Participants in the Diabetes Prevention Trial-Type 1
    Sosenko, Jay M.
    Palmer, Jerry P.
    Rafkin-Mervis, Lisa
    Krischer, Jeffrey P.
    Cuthbertson, David
    Mahon, Jeffery
    Greenbaum, Carla J.
    Cowie, Catherine C.
    Skyler, Jay S.
    DIABETES CARE, 2009, 32 (09) : 1603 - 1607
  • [27] Diabetic Subjects Diagnosed Through the Diabetes Prevention Trial-Type 1 (DPT-1) Are Often Asymptornatic With Normal A1C at Diabetes Onset
    Triolo, Taylor M.
    Chase, H. Peter
    Barker, Jennifer M.
    DIABETES CARE, 2009, 32 (05) : 769 - 773
  • [28] Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for Improving the Accuracy of the Risk Classification of Type 1 Diabetes
    Sosenko, Jay M.
    Skyler, Jay S.
    Mahon, Jeffrey
    Krischer, Jeffrey P.
    Greenbaum, Carla J.
    Rafkin, Lisa E.
    Beam, Craig A.
    Boulware, David C.
    Matheson, Della
    Cuthbertson, David
    Herold, Kevan C.
    Eisenbarth, George
    Palmer, Jerry P.
    DIABETES CARE, 2014, 37 (04) : 979 - 984
  • [29] THE DIABETES PREVENTION TRIAL-TYPE-1 DIABETES (DPT-1) - IMPLEMENTATION OF SCREENING AND STAGING OF RELATIVES
    不详
    DIABETES, 1995, 44 : A129 - A129
  • [30] Transient Diabetic Range Oral Glucose Tolerance Tests and Their Possible Relation to Insulin Resistance Prior to the Diagnosis of Type 1 Diabetes in the Diabetes Prevention Trial-Type 1(DPT-1)
    Sosenko, Jay M.
    Skyler, Jay S.
    Krischer, Jeffrey P.
    Greenbaum, Carla J.
    Rafkin, Lisa
    Mahon, Jeffrey L.
    Cuthbertson, David
    Palmer, Jerry P.
    DIABETES, 2010, 59 : A499 - A499
12345